Our findings demonstrate that PCIF1 selectively represses MTF2 translation, leading to tumour progression, which aligns with the role of m6Am modifications as previously reported in several cancers, such as colorectal cancer, glioblastoma and gastric cancer. The gene discussed is MTF2; the disease is neoplasm.